On a Tuesday night not too long ago, four plates arrived at a specific table at Elliot’s in Hackney before anyone had placed an order for a main course, and no one seemed to mind. Toast with anchovies, cheese puffs, and a few pieces of mangalitsa saltimbocca. The menu was never requested again. That’s what’s happening in Britain’s restaurants right now, in miniature, and the numbers behind it are probably larger than most patrons are aware.
A widely reported industry survey indicates that 57% of British consumers regularly replace large meals with smaller, snack-style meals. It’s a startling number that merits consideration because it goes beyond simply describing a menu trend. It talks about how people’s eating habits are subtly altered when they go out.
A portion of this is blatantly cultural. For more than ten years, small plates restaurants and natural wine bars have been making their way into British cities, transforming starters into the main event and elevating “snacks” from an afterthought to a serious culinary category. Chefs have embraced it, frequently with joy. Since 2012, the Isle of Mull cheese puffs at Elliot’s have outlasted almost every other dish on the menu. One co-owner described them as a happy accident in the kitchen. You can learn something about appetite, both literally and culturally, from that kind of persistence.
However, another force at work is more related to biology than taste. GLP-1 drugs are currently used by an estimated 2.5 million people in the UK, and the implications for eateries are becoming difficult to overlook. Individuals who use these drugs tend to eat less, eat out less frequently, and reserve regular dining out for special occasions. Researchers have discovered that they are significantly more likely to treat dinner as an occasion rather than a habit, and they are about a third less likely to go out at all. It’s easy to understand why operators are anxious. When multiplied across an entire industry, lower spend per head, shorter visits, and fewer wine sales are not insignificant figures.
The way restaurants are reacting is intriguing and somewhat unresolved. Some are fully committed: Chipotle now offers a high-protein option designed for denser, smaller meals, and Heston Blumenthal’s Fat Duck introduced a scaled-down “Mindful Experience.” Some are engaging in more subdued forms of resistance. It seems as though chefs have grown weary of serving ingredients like poetry rather than dinner, as a few recent London openings have begun to shift back toward heartier, traditional portions. It is difficult to determine whether that is a true correction or merely a contrarian pocket within a much broader trend.
Speaking with people in the hospitality industry gives me the impression that nobody is completely confident in their own forecasts. The sensible middle ground is fermented, nutrient-dense small plates, according to dietitians. Directors of marketing discuss premiumization. In the meantime, customers continue to order four snacks rather than one main course, sometimes without even realizing it. How long the drugs and the conversation surrounding them remain popular will likely determine whether that lasts forever or fades like so many other dining trends.
FAQs
1. What percentage of British diners now substitute meals with snacks?
57 percent, according to industry survey data.
2. What’s driving the small plates trend in the UK?
Rising GLP-1 weight-loss drug use alongside the existing small-plates dining culture.
3. How many people in the UK use GLP-1 medications?
Around 2.5 million people currently use drugs like Ozempic and Mounjaro.
4. How are restaurants adapting to smaller appetites?
Some offer scaled-down tasting menus; others add high-protein options.
5. Is the small plates trend reversing at all?
Yes, some London restaurants are returning to heartier, maximalist portions.
